Chacon J, Faizuddin F, McKee J, Sheikh A, Vasquez Jr V, Gadad S
Cancers (Basel). 2025; 17(5).
PMID: 40075661
PMC: 11899421.
DOI: 10.3390/cancers17050813.
Gantier M, Menoret S, Fourrier A, Delbos F, Nguyen T, Anegon I
Front Immunol. 2025; 16:1507317.
PMID: 40070824
PMC: 11893836.
DOI: 10.3389/fimmu.2025.1507317.
Fanijavadi S, Hansen T, Zedan A
Biomolecules. 2025; 15(2).
PMID: 40001576
PMC: 11852595.
DOI: 10.3390/biom15020273.
Imaoka Y, Ohira M, Nakayama T, Akabane M, Tajima T, Yokota S
Cell Transplant. 2025; 33:9636897241283289.
PMID: 39907091
PMC: 11459526.
DOI: 10.1177/09636897241283289.
Lau V, Mead G, Varyova Z, Mazet J, Krishnan A, Roberts E
Nat Commun. 2025; 16(1):2.
PMID: 39746898
PMC: 11696141.
DOI: 10.1038/s41467-024-54791-0.
IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP.
Ureshino H, Kamachi K, Kidoguchi K, Kimura S
EJHaem. 2024; 5(6):1278-1282.
PMID: 39691242
PMC: 11647684.
DOI: 10.1002/jha2.1053.
A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.
Bullock K, Hasaka T, Days E, Bauer J, Ward P, Richmond A
Cancers (Basel). 2024; 16(23).
PMID: 39682260
PMC: 11639798.
DOI: 10.3390/cancers16234075.
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness.
Bilev E, Wild N, Momayyezi P, Sala B, Sun R, Sandalova T
PLoS Pathog. 2024; 20(12):e1012755.
PMID: 39652590
PMC: 11658698.
DOI: 10.1371/journal.ppat.1012755.
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell Leukemia.
Buri M, Shoeb M, Bykov A, Repiscak P, Baik H, Dupanovic A
Cancer Immunol Res. 2024; 13(3):430-446.
PMID: 39642167
PMC: 7617306.
DOI: 10.1158/2326-6066.CIR-24-0189.
Human decidua basalis mesenchymal stem/stromal cells enhance anticancer properties of human natural killer cells, .
Almutairi A, Alshehri N, Subayyil A, Bahattab E, Alshabibi M, Abomaray F
Front Cell Dev Biol. 2024; 12:1435484.
PMID: 39539962
PMC: 11557523.
DOI: 10.3389/fcell.2024.1435484.
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.
Chen S, Zhu H, Jounaidi Y
Signal Transduct Target Ther. 2024; 9(1):302.
PMID: 39511139
PMC: 11544004.
DOI: 10.1038/s41392-024-02005-w.
Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56CD16 natural killer cells.
Wang R, Hu M, Lozzi I, Jin C, Ma D, Splith K
Int J Cancer. 2024; 156(3):638-651.
PMID: 39400317
PMC: 11621990.
DOI: 10.1002/ijc.35209.
Interleukin signaling in the regulation of natural killer cells biology in breast cancer.
Xu J, Gao H, Azhar M, Xu H, Chen S, Li M
Front Immunol. 2024; 15:1449441.
PMID: 39380989
PMC: 11459090.
DOI: 10.3389/fimmu.2024.1449441.
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives.
Rados M, Landegger A, Schmutzler L, Rabidou K, Taschner-Mandl S, Fetahu I
Cancer Metastasis Rev. 2024; 43(4):1401-1417.
PMID: 39294470
PMC: 11554946.
DOI: 10.1007/s10555-024-10212-8.
Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.
Pouxvielh K, Marotel M, Drouillard A, Villard M, Moreews M, Bossan A
Sci Adv. 2024; 10(35):eadn0164.
PMID: 39196934
PMC: 11352832.
DOI: 10.1126/sciadv.adn0164.
Natural killer cells and engagers: Powerful weapons against cancer.
Bottino C, Picant V, Vivier E, Castriconi R
Immunol Rev. 2024; 328(1):412-421.
PMID: 39180430
PMC: 11659922.
DOI: 10.1111/imr.13384.
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors.
Peng L, Sferruzza G, Yang L, Zhou L, Chen S
Cell Mol Immunol. 2024; 21(10):1089-1108.
PMID: 39134804
PMC: 11442786.
DOI: 10.1038/s41423-024-01207-0.
Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy.
Jung H, Paust S
Front Immunol. 2024; 15:1443366.
PMID: 39114657
PMC: 11304008.
DOI: 10.3389/fimmu.2024.1443366.
Cell-cell communication: new insights and clinical implications.
Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J
Signal Transduct Target Ther. 2024; 9(1):196.
PMID: 39107318
PMC: 11382761.
DOI: 10.1038/s41392-024-01888-z.
Human NK cells and cancer.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D
Oncoimmunology. 2024; 13(1):2378520.
PMID: 39022338
PMC: 11253890.
DOI: 10.1080/2162402X.2024.2378520.